Clinical Trial Update: Platelet-Inhibitor Drug Trial in Coronary Angioplasty [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a platelet-inhibitor drug in patients undergoing coronary angioplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Platelet-Inhibitor Drug

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Angina Pectoris, Cardiovascular Diseases | Phase 3 | Status: COMPLETED